Overview


According to FutureWise analysis the market for Ocular Surgery is expected to register a CAGR of 5.70% from 2024-2032.

In ocular surgery, eye diseases such as glaucoma, cataracts, refractive errors, and vitreoretinopathy are treated in order to restore sight. Around the world, cataracts and glaucoma are the leading causes of blindness. A cataract is a cloudy appearance of the human eye lens caused by the build-up of proteins and fibers inside the lens. Clouded, blurry, or dim vision, sensitivity to light and glare, fading or yellowing of colors are some of the symptoms of cataracts. A cataract surgery can be performed to replace a cloudy eye lens with an artificial intraocular lens to restore a patient's proper vision. Glaucoma is a group of eye conditions that damage the optic nerve, resulting in blindness. One of the most common types of glaucoma is open-angle glaucoma, which causes slow vision loss over time. Open-angle glaucoma can be treated with eye drops, laser treatment, and ocular surgery. The treatment of refractive errors of the eye can be performed with Exciplex lasers, YAG (yttrium aluminum garnet) lasers, Microkeratomes, or Femtosecond lasers.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Ocular Surgery Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Ocular Surgery Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Johnson & Johnson Services, Inc.
  • Vision Care
  • Alcon
  • Carl Zeiss AG
  • Meditec Medical Ltd.
  • Bausch & Lomb Incorporated
  • Ellex
  • Ziemer Ophthalmic Systems
  • Topcon Corporation
  • D.O.R.C. Dutch Ophthalmic Research Center (International) B.V.
  • Lumenis Be Ltd.
  • Glaukos Corporation
  • Aaren Scientific Inc.
  • HOYA Corporation
  • Rayner Intraocular Lenses Limited
  • SCHWIND eye-tech-solutions
  • Avedro
  • LENSAR, Inc.
  • iVIS Technologies

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Procedure Type

  • Cataract Surgery
  • Glaucoma Surgery
  • Vitrectomy Surgery
  • Refractive Error Surgery

By Device Type

  • Cataract Surgery Devices
    • IOL (Intraocular Lenses)
    • OVD (Ophthalmic Viscosurgical Devices)
    • Phacoemulsification Devices
  • Glaucoma Surgery Devices
    • GDD (Glaucoma Drainage Device)
    • Implants and Stents
    • Lasers and Systems
  • Vitrectomy Surgery Devices
    • Vitrectomy Packs
    • Vitrectomy Machines
  • Refractive Error Surgery Devices
    • Exciplex lasers
    • YAG (yttrium aluminum garnet) Lasers
    • Microkeratomes
    • Femtosecond Lasers

By End User

  • Hospitals
  • Ophthalmic clinics
  • Others (Academic and Research Institutions, among others)

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Ocular Surgery Market By Procedure Type, By Device Type, By End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

 

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Ocular Surgery Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Ocular Surgery Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Ocular Surgery Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Ocular Surgery Market, By Procedure Type Historical Analysis and Forecast 2024-2032 (USD Million)
    •   1. Cataract Surgery
        2. Glaucoma Surgery
        3. Vitrectomy Surgery
        4. Refractive Error Surgery

  • 8.   Ocular Surgery Market, By Device Type Historical Analysis and Forecast 2024-2032 (USD Million)
    •   1. Cataract Surgery Devices
         1.1. IOL (Intraocular Lenses)
         1.2. OVD (Ophthalmic Viscosurgical Devices)
         1.3. Phacoemulsification Devices
        2. Glaucoma Surgery Devices
         2.1. GDD (Glaucoma Drainage Device)
         2.2. Implants and Stents
         2.3. Lasers and Systems
        3. Vitrectomy Surgery Devices
         3.1. Vitrectomy Packs
         3.2. Vitrectomy Machines
        4. Refractive Error Surgery Devices
         4.1. Exciplex lasers
         4.2. YAG (yttrium aluminum garnet) Lasers
         4.3. Microkeratomes
         4.4. Femtosecond Lasers

  • 9.   Ocular Surgery Market, By End User Historical Analysis and Forecast 2024-2032 (USD Million)
    •   1. Hospitals
        2. Ophthalmic clinics
        3. Others (Academic and Research Institutions, among others)

  • 10.   North America Ocular Surgery Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2024-2032

  • 11.   Latin America Ocular Surgery Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2024-2032

  • 12.   Europe Ocular Surgery Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2024-2032

  • 13.   Asia Pacific Ocular Surgery Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2024-2032

  • 14.   Middle East and Africa Ocular Surgery Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2024-2032

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Johnson & Johnson Services, Inc.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Vision Care
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Alcon
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Carl Zeiss AG
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Meditec Medical Ltd.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Bausch & Lomb Incorporated
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Ellex
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Ziemer Ophthalmic Systems
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Topcon Corporation
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. D.O.R.C. Dutch Ophthalmic Research Center (International) B.V.
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Lumenis Be Ltd.
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Glaukos Corporation
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13 .Aaren Scientific Inc.
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. HOYA Corporation
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. Rayner Intraocular Lenses Limited
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
        16. SCHWIND eye-tech-solutions
         16.1. Company Overview
         16.2. Product Portfolio
         16.3. SWOT Analysis
         16.4. Financial Overview
         16.5. Strategic Overview
        17. Avedro
         17.1. Company Overview
         17.2. Product Portfolio
         17.3. SWOT Analysis
         17.4. Financial Overview
         17.5. Strategic Overview
        18. LENSAR, Inc.
         18.1. Company Overview
         18.2. Product Portfolio
         18.3. SWOT Analysis
         18.4. Financial Overview
         18.5. Strategic Overview
        19. iVIS Technologies
         19.1. Company Overview
         19.2. Product Portfolio
         19.3. SWOT Analysis
         19.4. Financial Overview
         19.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
                  administrations
        5. The overall economic slowdown of the developing and developed nations

  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients